» Articles » PMID: 39203977

A Simple and Versatile Method for Ex Vivo Monitoring of Goat Vaginal Mucosa Transduction by Viral Vector Vaccines

Overview
Date 2024 Aug 29
PMID 39203977
Authors
Affiliations
Soon will be listed here.
Abstract

Goat may represent a valid large animal model for human pathogens and new vaccines testing. Appropriate vaccine administration is a critical component of a successful immunization program. The wrong route of administration may reduce the efficacy of the vaccine, whereas the proper administration strategy can enhance it. Viral vectors have been employed successfully for goat and sheep immunization; however, no data concerning the vaginal route are available. A viral vector's ability to transduce the site of inoculation is of primary interest. In this study, a fast and reliable ex vivo assay for testing the transduction capability of an Ad5-based vector when intravaginally administered was developed. An Ad5 vector delivering an expression cassette with a bicistronic reporter gene, Ad5-CMV-turboGFP-IRES-Luc2, was constructed. We demonstrated Ad5-CMV-turboGFP-IRES-Luc2's ability to transduce caprine vaginal mucosa by ex vivo bioluminescent imaging (BLI) employing a simple CCD camera apparatus for chemiluminescence western immunoblotting. These data, though simple, provide valuable insights into developing a vaginal immunization strategy using a viral vector-based vaccine to protect against pathogens causing genital diseases.

References
1.
Begum S, Nooruzzaman M, Hasnat A, Parvin M, Parvin R, Islam M . Isolation of peste des petits ruminants virus using primary goat kidney cell culture from kidneys obtained at slaughter. Vet Med Sci. 2020; 7(3):915-922. PMC: 8136951. DOI: 10.1002/vms3.413. View

2.
De Clercq E, Kalmar I, Vanrompay D . Animal models for studying female genital tract infection with Chlamydia trachomatis. Infect Immun. 2013; 81(9):3060-7. PMC: 3754237. DOI: 10.1128/IAI.00357-13. View

3.
Gordon S, Kines R, Kutsyna G, Ma Z, Hryniewicz A, Roberts J . Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA. J Immunol. 2011; 188(2):714-23. PMC: 3253208. DOI: 10.4049/jimmunol.1101404. View

4.
Whaley K, Hanes J, Shattock R, Cone R, Friend D . Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res. 2010; 88 Suppl 1:S55-66. DOI: 10.1016/j.antiviral.2010.09.006. View

5.
Tempesta M, Crescenzo G, Camero M, Bellacicco A, Tarsitano E, Decaro N . Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens. Antimicrob Agents Chemother. 2008; 52(11):4064-8. PMC: 2573114. DOI: 10.1128/AAC.00725-08. View